The launch of GLP-1 weight-loss drugs in India is gaining popularity. Harvard researchers share a comprehensive guidance for ...

GLP-1 drugs may be hailed as a medical breakthrough in obesity care, but Indian experts warn they are no cosmetic quick-fix.

A recent Canadian study reveals a significant surge in obesity rates, with 32.7 percent of adults classified as obese in 2023, a notable increase since 2009. The COVID-19 pandemic is identified as a ...